Danish company prepares to take the psoriasis market by storm – seeks FDA approval
!["We have peace of mind, because it feels like we are doing the right things. We are constantly building up our case," says Jesper J. Lange, Administrative Drector for MC2 Therapeutics. | Photo: MC2 Therapeutics / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article11640234.ece/ALTERNATES/schema-16_9/MC2.jpg)
MC2 Therapeutics, which is based in Hørsholm, has quietly developed a product that could have a significant impact on the American market for psoriasis treatment.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Danish company takes candidate to phase III
For subscribers